BRCA1 mutations were more common (12.2% among breast cancer cases diagnosed at age 40 or below), while mutations in the BRCA2 gene were rare (0.08% in breast cancer patients diagnosed at age 40 or below). Here, BRCA2 is linked to breast carcinoma.